Clinical trials
Terminated Leukemia trials in Australia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2010 | 2 |
| 2011 | 1 |
| 2012 | 1 |
| 2014 | 3 |
| 2019 | 2 |
| 2021 | 2 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 14 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Therapeutic Advances in Childhood Leukemia Consortium | 3 |
| Bristol-Myers Squibb | 2 |
| Novartis Pharmaceuticals | 2 |
| Amgen | 1 |
| Ariad Pharmaceuticals | 1 |
| Baxalta now part of Shire | 1 |
| CRISPR Therapeutics AG | 1 |
| GlaxoSmithKline | 1 |
| Institut de Recherches Internationales Servier | 1 |
| Shengke Pharmaceuticals Pty Ltd | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia | 14 |
| Recurrence | 6 |
| Lymphoma | 5 |
| Leukemia, Myeloid, Acute | 4 |
| Lymphoma, Non-Hodgkin | 4 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 4 |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 3 |
| Neoplasms | 3 |
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 3 |
| Bone Marrow Diseases | 2 |
Trials
Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.